Paloma Partners’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-84,099
Closed -$1.54M 2218
2021
Q1
$1.54M Buy
+84,099
New +$1.38M 0.03% 510
2020
Q4
Sell
-53,323
Closed -$598K 2158
2020
Q3
$598K Buy
+53,323
New +$525K 0.02% 1039
2020
Q1
Sell
-34,097
Closed -$429K 1979
2019
Q4
$429K Buy
34,097
+4,865
+17% +$52.4K 0.01% 1498
2019
Q3
$261K Buy
+29,232
New +$256K 0.01% 1611
2019
Q2
Sell
-22,868
Closed -$174K 2113
2019
Q1
$174K Buy
+22,868
New +$184K ﹤0.01% 1545
2018
Q3
Sell
-75,400
Closed -$737K 1900
2018
Q2
$737K Sell
75,400
-80,322
-52% -$789K 0.01% 845
2018
Q1
$1.45M Sell
155,722
-10,910
-7% -$104K 0.02% 769
2017
Q4
$1.58M Buy
166,632
+115,354
+225% +$1.1M 0.02% 796
2017
Q3
$530K Buy
+51,278
New +$473K 0.01% 1498
2017
Q1
Sell
-45,173
Closed -$322K 2209
2016
Q4
$322K Buy
+45,173
New +$314K ﹤0.01% 1684
2016
Q2
Sell
-105,304
Closed -$670K 2318
2016
Q1
$670K Buy
+105,304
New +$565K 0.01% 1152
2015
Q3
Sell
-20,503
Closed -$179K 1886
2015
Q2
$179K Buy
+20,503
New +$172K ﹤0.01% 1585
2014
Q4
Sell
-37,413
Closed -$242K 1336
2014
Q3
$242K Buy
+37,413
New +$289K 0.01% 790

Other funds holding SEM

Paloma Partners's SEM Position: Q2 2021 in Review

Paloma Partners sold out of Select Medical (SEM) in Q2 2021, closing a stake of 84,099 shares — an estimated $1.54M sold.

Paloma Partners first reported a position in SEM in Q3 2014 and held it in 13 quarters. The position peaked at $1.58M in Q4 2017. 264 funds tracked by Wall St. Rank hold SEM as of Q2 2021.

  • Paloma Partners reported no remaining Select Medical position as of Q2 2021 after selling out during the quarter.
  • Paloma Partners sold 84,099 Select Medical shares in Q2 2021, an estimated $1.54M.
  • Paloma Partners first reported a position in Select Medical in Q3 2014 and held it in 13 quarters.
  • Paloma Partners's Select Medical position peaked at $1.58M in Q4 2017.
  • 264 funds tracked by Wall St. Rank held Select Medical as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.